These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3573507)

  • 1. [Prognosis of isoniazid-resistant patients of pulmonary tuberculosis].
    Yoshida F; Liu C
    Kekkaku; 1987 Jan; 62(1):17-24. PubMed ID: 3573507
    [No Abstract]   [Full Text] [Related]  

  • 2. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treatment of newly detected pulmonary tuberculosis with rifampin combined with isoniazid and ethambutol].
    Szymański A; Walecki J; Czaplińska-Jóźwiak E; Kuczborska Z; Gaik A; Bilczak Z; Swiatnicka I; Swica T; Zdawski T
    Pneumonol Pol; 1980 Nov; 48(11):669-74. PubMed ID: 7255207
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical trial of short-course chemotherapy for pulmonary tuberculosis patients (author's transl)].
    Kameda K; Kino C
    Kekkaku; 1974 Nov; 49(11):387-91. PubMed ID: 4455991
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment efficacy in destructive forms of pulmonary tuberculosis in relation to the methods of administering rifadin and isoniazid].
    Shevchenko RN; German AK; Akhtyrskiĭ AI; Smirnova VV
    Vrach Delo; 1989 Jun; (6):76-8. PubMed ID: 2781771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of the treatment of newly diagnosed patients with destructive tuberculosis of the lungs using rifampicin in combination with other drugs].
    Roslik SM; Pashkov IuN; Gerasimova TG; Marveeva SL
    Probl Tuberk; 1990; (5):75-6. PubMed ID: 2388900
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
    Szymanski A; Gaik A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):181-3. PubMed ID: 6273991
    [No Abstract]   [Full Text] [Related]  

  • 13. [The short course therapies by Ryoken's method. 9 month and 12 month regimens including rifampicin (RFP) plus isoniazid (INH) in bacteriologically proved pulmonary tuberculosis].
    Gomi J; Aoyagi T; Fukuhara Y; Yamaguchi T; Matsumiya T
    Kekkaku; 1985 Aug; 60(8):435-45. PubMed ID: 3906218
    [No Abstract]   [Full Text] [Related]  

  • 14. A Singapore study of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis (1).
    Lee SK
    Bull Int Union Tuberc; 1976; 51(1):109-13. PubMed ID: 1030269
    [No Abstract]   [Full Text] [Related]  

  • 15. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK; Kim CT; Song SD
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
    Moulding TS; Le HQ; Rikleen D; Davidson P
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous rifampicin therapy in open tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; Schwabe HK; Hengstmann J; Eichelbaum M
    Med Welt; 1983 Jun; 34(24):701-3. PubMed ID: 6888237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.